CoreRx®a CDMO with a focus on early phase drug product development, offering state of the art facilities to support your supply chain needs throughout the entire clinical trial process. Our integrated offerings provide comprehensive services for the development, manufacturing and testing of solid, liquid and semi-solid dosage forms.
The art of drug product development is the core of what we do. We differentiate ourselves by mixing highly experienced scientists with a wide range of technologies to deliver optimal solutions to meet our clients’ needs. From simple formulations to complex, delayed or targeted release dosage forms, CoreRx’s solutions maximize client investments, shorten development time and reduce overall costs.
At CoreRx, you bring us your formulation challenge and we will supply the right ingredients to ensure your product reaches its maximum potential.
Dr. Todd R. Daviau, president and CEO of CoreRx, and other key members of the management team present an overview of the company’s comprehensive drug product development and manufacturing services for the pharmaceutical and biotechnology industries.
The position is a key hire to the Quality Assurance team and plays a major role in ensuring the company’s compliance to GMP. The position plays a major role within the QA department and the company in ensuring compliance to GMP, FDA and ISO requirements.